Key Insights

Highlights

Success Rate

67% trial completion

Research Leaders

7 sponsors active, led by University Hospital, Strasbourg, France

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 87/100

Termination Rate

33.3%

1 terminated out of 3 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

67% success

Data Visualizations

Phase Distribution

Trial Status

Completed2
Terminated1

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Research Network

Active Sponsors

  • University Hospital, Strasbourg, France1
  • Malaysian Endocrine and Metabolic Society1
  • National University of Malaysia1
  • University of Malaya1
  • Karolinska Institutet1

Top Investigators

Related Conditions

  • Atrial Fibrillation2
  • Graves Disease1
  • Hashimotos Thyroiditis1
  • Hyperthyroidism1
  • Hypothyroidism1

Activity Timeline